Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220013142 220019722 1.8 null Palliative (P) 2015-11-03 2015-11-04 Cytarabine Low Dose N null 220029244 CYTARABINE
220013143 220007580 1.7 28.5 Palliative (P) 2015-05-26 2015-05-27 null 2 N 220029247 NOT MATCHED
220013144 220007580 1.65 null null 2015-06-17 2015-06-18 Hydroxycarbamide 02 N 220029247 HYDROXYCARBAMIDE
220013145 220007581 1.58 64 Disease modification (D) 2014-10-20 2014-10-20 CYTARABINE 02 N 220029264 CYTARABINE
220013146 220007581 null 117 Palliative (P) 2012-03-29 2014-04-05 Cytarabine Low Dose N N 220029264 CYTARABINE
220013147 220007581 0 null Palliative (P) 2017-03-11 2017-03-11 Cytarabine Low Dose 2 N 220029264 CYTARABINE
220013148 220014175 1.52 54 Curative (C) null 2017-08-02 APML Induction SR ATRA,Idarubicin N N 220029269 NOT MATCHED
220013150 220007584 1.62 null Disease modification (D) 2015-05-25 2015-06-01 Cytarabine low (10to20mg/m2) IV/SC N N 220029273 CYTARABINE
220013151 220007584 null 65.3 Disease modification (D) 2016-07-20 2016-07-21 Hydroxycarbamide N N 220029273 HYDROXYCARBAMIDE
220013152 220007585 0 62 Disease modification (D) 2016-04-22 2016-04-23 CYTARABINE N null 220029278 CYTARABINE
220013153 220007586 null 0 Palliative (P) 2016-02-29 2016-03-01 Hydroxycarbamide 02 N 220029279 HYDROXYCARBAMIDE
220013154 220007586 1.54 null Adjuvant (A) 2013-09-17 2013-09-17 Hydroxycarbamide N N 220029279 HYDROXYCARBAMIDE
220013155 220007586 1.55 107.5 Adjuvant (A) 2015-01-30 2015-02-01 Hydroxycarbamide N N 220029279 HYDROXYCARBAMIDE
220013156 220007586 1.71 null Palliative (P) 2017-08-10 2017-08-12 DAUNORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE 1 N 220029279 NOT MATCHED
220013157 220007589 1.6 29 Curative (C) 2014-06-18 2014-06-25 AML MyeChild 01 Triple IT 02 N 220029293 NOT MATCHED
220013158 220007590 1.52 null Palliative (P) 2015-04-02 2015-04-07 CYTARABINE N N 220029294 CYTARABINE
220013159 220007590 0 8.4 Disease modification (D) 2017-11-09 2017-11-25 Amsacrine + CYTARABINE 02 N 220029294 NOT MATCHED
220013160 220007590 null 68.5 Disease modification (D) 2013-12-15 2013-12-16 Hydroxycarbamide 2 N 220029294 HYDROXYCARBAMIDE
220013161 220019725 null 63.3 null 2018-05-17 2018-05-20 Hydroxycarbamide null null 220029304 HYDROXYCARBAMIDE
220013162 220019725 1.77 null Palliative (P) 2018-05-28 2018-05-28 Cytarabine Low Dose N N 220029304 CYTARABINE
220013163 220007591 null 36.6 null 2014-07-30 2014-07-30 AML MyeChild 01 Triple IT N N 220029309 NOT MATCHED
220013164 220007591 1.44 0 Adjuvant (A) 2015-04-28 2015-04-28 Hydroxycarbamide 99 N 220029309 HYDROXYCARBAMIDE
220013165 220019726 null 85.6 Disease modification (D) 2016-08-08 2016-08-26 Hydroxycarbamide 02 N 220029313 HYDROXYCARBAMIDE
220013166 220007592 null 90.1 Palliative (P) null 2015-09-14 Hydroxycarbamide null N 220029319 HYDROXYCARBAMIDE
220013167 220007593 null null Palliative (P) 2017-02-02 2017-02-07 Cytarabine Low Dose 02 N 220029319 CYTARABINE
220013168 220007594 1.81 79 Palliative (P) 2018-07-03 2018-07-03 Cytarabine Low Dose N N 220029327 CYTARABINE
220013169 220007598 null 69.2 Curative (C) 2014-03-17 2014-05-28 Amsacrine + CYTARABINE N null 220029331 NOT MATCHED
220013170 220007599 1.65 62.2 Disease modification (D) 2014-08-13 2014-08-24 APML Consolidation II ATRA,Idarubicin 02 N 220029332 NOT MATCHED
220013171 220007600 null 66.8 Palliative (P) 2016-11-03 2016-11-08 null N null 220029334 NOT MATCHED
220013172 220007601 null null Disease modification (D) null 2014-01-16 CYTARABINE 02 N 220029336 CYTARABINE
220013173 220007601 null 33 Curative (C) 2017-12-12 2017-12-15 CLADRIBINE + CYTARABINE + MITOXANTRONE N null 220029336 NOT MATCHED
220013174 220017736 1.69 74.199 Adjuvant (A) 2015-12-11 2015-12-11 AML MyeChild N N 220029342 NOT MATCHED
220013175 220017736 1.69 88.6 Palliative (P) 2018-05-29 2018-06-24 Cytarabine Low Dose 2 N 220029342 CYTARABINE
220013176 220017736 0 82 Adjuvant (A) 2016-08-12 2016-08-12 Cytarabine Low Dose null N 220029342 CYTARABINE
220013177 220007602 1.61 68.8 Curative (C) 2013-05-21 2013-07-15 Cytarabine Low Dose Y N 220029359 CYTARABINE
220013178 220014185 null null Disease modification (D) 2018-03-19 2019-03-22 Hydroxycarbamide 2 Y 220029362 HYDROXYCARBAMIDE
220013179 220007603 0.68 null Palliative (P) 2013-11-11 2013-11-18 ALL Ph+ve Imatinib N N 220029364 NOT MATCHED
220013180 220007604 1.63 null Palliative (P) 2013-03-18 2013-03-21 Cytarabine low (10to20mg/m2) IV/SC N N 220029364 CYTARABINE
220013181 220007605 1.57 109.2 Disease modification (D) 2014-10-30 2014-10-30 Hydroxycarbamide N Y 220029369 HYDROXYCARBAMIDE
220013182 220007605 1.72 79.9 Palliative (P) null 2016-12-03 CYTARABINE 2 null 220029369 CYTARABINE
220013183 220017738 1.82 72.4 Disease modification (D) null 2013-03-16 CYTARABINE N N 220029388 CYTARABINE
220013184 220017738 0 82 Curative (C) 2017-08-26 2017-08-26 CYTARABINE 2 Y 220029388 CYTARABINE
220013185 220007606 null 39.4 Palliative (P) 2013-02-15 2013-02-15 AML MyeChild 01 FLA N N 220029391 NOT MATCHED
220013186 220007607 0.81 0 null 2016-05-13 2016-05-18 Hydroxycarbamide N N 220029391 HYDROXYCARBAMIDE
220013187 220007608 1.71 15.2 Disease modification (D) 2018-01-04 2018-01-04 AML Interim Guidelines FLA -Ida N N 220029393 NOT MATCHED
220013188 220007608 1.8 85 Palliative (P) 2017-05-08 2017-07-01 Hydroxycarbamide N N 220029393 HYDROXYCARBAMIDE
220013189 220007609 null null Disease modification (D) 2013-05-20 2013-05-31 Cytarabine Low Dose 2 N 220029397 CYTARABINE
220013190 220007609 1.51 14.3 Disease modification (D) 2015-05-25 2015-05-27 AML MyeChild 01 IT Cyt N N 220029397 NOT MATCHED
220013191 220017741 null 72 Palliative (P) 2017-01-20 2017-01-28 AML Relapsed FLA - DaunoXome 02 null 220029400 NOT MATCHED
220013192 220017741 1.8 74 Disease modification (D) 2016-02-10 2016-02-10 CYTARABINE 02 N 220029400 CYTARABINE